Tonix Pharmaceuticals Holding Corp. (TNXP) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1161757,
    "name": "Tonix Pharmaceuticals Holding Corp.",
    "stock_name": "Tonix Pharmaceuticals Holding Corp.",
    "full_name": "Tonix Pharmaceuticals Holding Corp.",
    "name_url": "stocks-analysis/tonix-pharmaceuticals-holding-corp",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "19.53",
    "chg": 4.01,
    "chgp": "25.84%",
    "dir": 1,
    "prev_price": "15.52",
    "mcapval": "221.69",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US8902608541",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "2.57 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/tonix-pharmaceuticals-holding-corp-1161757-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Tonix Pharmaceuticals Holding Corp. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-tonix-pharmaceuticals-holding-corp-technically-bullish-or-bearish-3547288",
        "imagepath": "",
        "date": "2025-09-20 19:51:56",
        "description": "As of 10 September 2025, the technical trend for Tonix Pharmaceuticals Holding Corp. has changed from mildly bearish to mildly bullish. The current stance is mildly bullish, primarily driven by the daily moving averages indicating a positive trend. However, the weekly MACD remains bearish, and the Bollinger Bands are bearish across both weekly and monthly time frames, suggesting some caution. The KST shows a mixed signal with a mildly bullish monthly reading but a mildly bearish weekly reading. Overall, the stock has underperformed against the S&P 500 in the short term, with a 1-week return of -9.10% compared to the benchmark's 1.05%, and a 1-month return of -29.20% versus 2.33%...."
      },
      {
        "title": "Is Tonix Pharmaceuticals Holding Corp. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-tonix-pharmaceuticals-holding-corp-overvalued-or-undervalued-3543692",
        "imagepath": "",
        "date": "2025-09-20 18:26:03",
        "description": "As of 9 November 2023, the valuation grade for Tonix Pharmaceuticals Holding Corp. has moved from does not qualify to risky. The company appears to be overvalued given its financial metrics, particularly with a Price to Book Value of 1.65 and an EV to Sales ratio of 16.56, which are significantly high for a loss-making entity. Additionally, the company has a negative ROCE of -148.11% and a negative ROE of -38.82%, indicating poor returns on capital and equity.\n\nIn comparison to peers, Tonix's valuation ratios are concerning; for instance, Aytu Biopharma, Inc. has a fair P/E ratio of 2.46, while Tonix's P/E is not applicable due to its loss-making status. Other risky peers like Biofrontera, Inc. and Impel Pharmaceuticals, Inc. also reflect negative valuation metrics. Notably, Tonix's stock has underperformed against the S&P 500 across multiple periods, including a -29.20% return over the past month compared ..."
      }
    ],
    "total": 7,
    "sid": "1161757",
    "stock_news_url": "https://www.marketsmojo.com/news/tonix-pharmaceuticals-holding-corp-1161757"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is Tonix Pharmaceuticals Holding Corp. technically bullish or bearish?

2025-09-20 19:51:56

As of 10 September 2025, the technical trend for Tonix Pharmaceuticals Holding Corp. has changed from mildly bearish to mildly bullish. The current stance is mildly bullish, primarily driven by the daily moving averages indicating a positive trend. However, the weekly MACD remains bearish, and the Bollinger Bands are bearish across both weekly and monthly time frames, suggesting some caution. The KST shows a mixed signal with a mildly bullish monthly reading but a mildly bearish weekly reading. Overall, the stock has underperformed against the S&P 500 in the short term, with a 1-week return of -9.10% compared to the benchmark's 1.05%, and a 1-month return of -29.20% versus 2.33%....

Is Tonix Pharmaceuticals Holding Corp. overvalued or undervalued?

2025-09-20 18:26:03

As of 9 November 2023, the valuation grade for Tonix Pharmaceuticals Holding Corp. has moved from does not qualify to risky. The company appears to be overvalued given its financial metrics, particularly with a Price to Book Value of 1.65 and an EV to Sales ratio of 16.56, which are significantly high for a loss-making entity. Additionally, the company has a negative ROCE of -148.11% and a negative ROE of -38.82%, indicating poor returns on capital and equity. In comparison to peers, Tonix's valuation ratios are concerning; for instance, Aytu Biopharma, Inc. has a fair P/E ratio of 2.46, while Tonix's P/E is not applicable due to its loss-making status. Other risky peers like Biofrontera, Inc. and Impel Pharmaceuticals, Inc. also reflect negative valuation metrics. Notably, Tonix's stock has underperformed against the S&P 500 across multiple periods, including a -29.20% return over the past month compared ...

View All News